Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case! Your contact information is not shown on the website.
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Use camera
Select from library
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!


IMPORTANT - Your report is queued
It may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Report by
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

If your report is poison related call 1-800-222-1222 for a free consultation with a live medical poisoning expert

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Boil Water Advisory, Highland Ave, Jaffrey, NH 03452, USA

6 days ago

Highland Avenue, Jaffrey, 03452 New Hampshire, United States

A boil water order in effect for most of Jaffrey, NH.

The area affected by this Boil Order includes everything west of Highland Ave: Highland Ave., Prospect St., Main St (west of Prospect St.)., Matchpoint Rd., Sawtelle Rd, Harkness Rd, Cutter Hill Rd., Bryant Road, Parsons Lane, Jaffrey Center, Thorndike Pond Road, Blackberry Lane, First Tavern Rd., Gilmore Pond Rd. Sandy Lane, Southerly from Main St. to Heath Rd., Dublin Rd., & Mountain Rd., Mark St.

Source: twitter.com
Source publication date: 2021 09 14

Related Reports

A precautionary Boil Water Notice was issued due to a water main break serving a neighborhood in North Fort Myers along New Post Road from Bayshore Road to the entrance of Old Bridge Village. The order includes about 650 customers.

Source: twitter.com
Source publication date: 2021 09... See More 20 See Less

Consolidated Waterworks/Sewerage District No. 1 of Bossier Parish has issued a boil advisory effective immediately. Authorities say the advisory is due to a power loss at the district’s water plant. This boil advisory affects residents in the Dogwood, Dogwood Park and Dogwood South neighborhoods serviced by the... See More Consolidated Waterworks/Sewerage District No. 1 water system.

Source: bossiernow.com
Source publication date: 2021 09 20
See Less

Numerous areas of Estill County are under a boil water advisory. As of 10:20 a.m. on Monday, Sept. 20, the following areas were affected:

Trotting Ridge Rd
O’Possum Run Rd
Blue Run Rd
Lincoln Farm Rd
Henry White Rd
Phyllis Ann Court
Elmer Richardson Rd
Brittany Lane... See More Alberta Drive
Drowning Creek Rd
Ben Hunt Rd
Picnic Hill Rd
Apple Blossom Rd
Majestic Drive
Candy Lane
Judy Lane
Placid Drive
Picnic Loop
Beechwood Drive
Hammons Way
Lafayette Circle
Jr Furniture Rd

Source: twitter.com
Source publication date: 2021 09 20
See Less

The Arkansas Department of Health issued Monday afternoon a boil water order for the Mockingbird Hill Water Association. The order was issued due to a broken water main.

Source: newtoncountytimes.com
Source publication date: 2021 09 20 See Less

The town of Brooksville water customers are under a boil water notice.

Source: wcbi.com
Source publication date: 2021 09 20 See Less

The Stephens Regional Special Utility District has issued a Boil Water Notice for all of its customers, effective immediately.

Source: breckenridgetexan.com
Source publication date: 2021 09 20 See Less

Numerous areas of Estill County are under a boil water advisory.

As of 10:20 a.m. on Monday, Sept. 20, the following areas were affected:

Trotting Ridge Rd
O’Possum Run Rd
Blue Run Rd
Lincoln Farm Rd
Henry White Rd
Phyllis Ann Court
Elmer Richardson Rd
Brittany Lane... See More Alberta Drive
Drowning Creek Rd
Ben Hunt Rd
Picnic Hill Rd
Apple Blossom Rd
Majestic Drive
Candy Lane
Judy Lane
Placid Drive
Picnic Loop
Beechwood Drive
Hammons Way
Lafayette Circle
Jr Furniture Rd

Source: wtvq.com
Source publication date: 2021 09 20
See Less

A boil advisory has been announced for part of the city of Linn. The advisory is for people and businesses on the west side of the city.

It affects businesses and homes that use city water on Old Mill Road, Clay Street.

Source: krcgtv.com
Source publication date:... See More 2021 09 20 See Less

The Town of Oberlin will be shutting down its water supply temporarily today due to a water main break on Hwy 26.

Water service will be turned back on once repairs are complete. The town will remain under a boil advisory once water service is returned.

Source:... See More kplctv.com
Source publication date: 2021 09 20
See Less

Pacific Gas & Electric announced that a Public Safety Power Shutoff (PSPS) has been scheduled for Tuesday morning and will affect some residents in the Santa Ynez area.

The power shutoff is scheduled to begin at 7 a.m. on Tuesday, Sept. 21, ahead of dry, gusty winds... See More that were forecasted to occur.

PG&E said this shutoff will impact 19 PG&E serviced households and businesses located northeast of Santa Ynez and Highway 154 as well as along portions of Figueroa Road and Catway Road south to Mora Road.

More than 7,100 PG&E customers have been notified that a PSPS is going to occur.

Outage link: pgealerts.alerts.pge.com

Source: keyt.com
Source publication date: 2021 09 20
See Less

Recent Interesting Reports

Company name: ICU Medical, Inc.
Brand name: Hospira
Product recalled: Aminosyn II, 15%, An Amino Acid Injection, Sulfite
Reason of the recall: Presence of visible particulate matter
FDA Recall date: September 07, 2021
Recall details: ICU Medical, Inc. is voluntarily recalling one lot (2,112 units) of Aminosyn... See More II, 15%, An Amino Acid Injection, Sulfite Free intravenous (IV) solution to the hospital/user level due to the presence of visible particulate matter identified as fibers, hair, and proteinaceous material along with other particles. 

ICU Medical became aware of this issue while inspecting retain samples as part of routine process. Administration of a drug product that contains particulate matter could result in adverse events ranging from inflammation at the site of injection to more serious events that could include the formation of a blood clot obstructing the flow of blood which could lead to end-organ damage or death. 

To date, ICU Medical, Inc. has not received reports of adverse events or illnesses related to this recall. Aminosyn II, Sulfite-Free, (an amino acid injection) infused with dextrose by peripheral vein infusion is indicated as a source of nitrogen in the nutritional support of patients with adequate stores of body fat, in whom, for short periods of time, oral nutrition cannot be tolerated, is undesirable, or inadequate. 

Aminosyn II can be administered peripherally with dilute (5 to 10%) dextrose solution and I.V. fat emulsion as a source of nutritional support. This form of nutritional support can help to preserve protein and reduce the breakdown of organic or inorganic materials, such as proteins, sugars, fatty acids, etc. in stress conditions where oral intake is inadequate. Aminosyn II is also indicated for central vein infusion to prevent or reverse excreting more nitrogen than is being taken in in patients where the intestinal tract, by the oral, surgical opening into the stomach for the introduction of food or surgical procedure for a feeding tube routes cannot or should not be used and gastrointestinal absorption of protein is impaired. 

Product was distributed nationwide both by ICU Medical direct to customers and through medical distributors. The product is for human use only. ICU Medical acquired this product from Hospira, a Pfizer company; therefore, the affected product contains a Hospira NDC number and a Hospira label. The affected product lot, manufactured in the U.S. by ICU Medical in November 2020, is listed below:  

- Aminosyn® II 15% An Amino Acid Injection, Sulfite-Free. NDC: 0409-7171-17. Catalog Number: 07171-17. Lot Number: 4989094. Expiration Date: 01-Apr-2022. Configuration: Pharmacy Bulk. Package 2-liter. Flexible. Container. Manufacture Date: November 2020. Distribution Dates: January 2021 – March 2021.

ICU Medical is notifying its distributors and customers of this recall by letter and is arranging for the return of all recalled products.

Hospitals/distributors that have a product that is being recalled should stop use/further distribution and return to the place of purchase.

Customers with questions regarding this recall can call ICU Medical at 1-844-654-7780 Monday through Friday between the hours of 8 a.m. and 5 p.m. Central time. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using these drug products.

Check the full recall details on fda.gov

Source: FDA
See Less

Company name: Jacobus Pharmaceutical Company Inc.
Brand name: Ruzurgi®
Product recalled: Ruzurgi® (amifampridine) 10 mg tablets
Reason of the recall: Exceeds Specification for Total Yeast and Mold Counts
FDA Recall date: September 13, 2021
Recall details: Plainsboro, New Jersey, Jacobus Pharmaceutical Company Inc. is voluntarily recalling 3... See More lots of Ruzurgi® (amifampridine) 10 mg tablets to the consumer level. The products have been found to be contaminated with yeast, mold, and aerobic bacteria based on laboratory test results.

Oral products heavily contaminated with yeast, mold, and aerobic bacteria may result in serious and life-threatening infections. The use of the defective product in patients with underlying immunosuppressive conditions such as Lambert Eaton Syndrome (LEMS) increases the concern for serious infections.

The product is used as a treatment for LEMS in patients ages 6 to less than 17 and is packaged in 100 count bottles (NDC: 49938-110-01). The affected Ruzurgi® (amifampridine) tablets lots include the following control numbers and expiration dates:
- Control Number 18038, Expiration 03/2023
- Control Number 18039, Expiration 03/2023
- Control Number 18079, Expiration 05/2023

The Control Number is located to the right of the bottle’s front panel below the D2 Barcode. Ruzurgi® (amifampridine) was distributed worldwide to specialty pharmacies and physicians.

Jacobus was informed of this issue by their Canadian partner that was conducting confirmatory full testing on Control Number 18038. Jacobus conducted an expanded investigation which identified Control Numbers 18039 and 18079.

- Control Number 18038 was distributed between 05/25/2021 – 08/26/2021 (Canada only)
- Control Number 18039 was distributed between 06/01/2021 – 08/10/2021
- Control Number 18079 was distributed between 08/10/2021 – 08/30/2021

Jacobus Pharmaceutical Company Inc is notifying its distributors and customers via regular mail and electronic mail and is arranging for the return of all recalled products.

Consumers that have Ruzurgi® (amifampridine) which is being recalled should stop using and return this product. Consumers with questions regarding this recall can contact Jacobus Pharmaceutical Company Inc. by phone at (609)799-8221 ext. 2120, Monday thru Friday from 9:00 AM to 5:00 PM Eastern Standard Time. This recall is being conducted with the knowledge of the U.S. Food and Drug Administration and other health authorities.

Check the full recall details on fda.gov

Source: FDA
See Less

Company name: Teligent Pharma, Inc.
Brand name: Teligent
Product recalled: Lidocaine HCl Topical Solution 4%
Reason of the recall: Super potency
FDA Recall date: August 30, 2021
Recall details: Teligent Pharma, Inc. is voluntarily recalling one lot of Lidocaine HCl Topical Solution 4%, 50ml in a screw... See More cap glass bottle to the user level. The product is being recalled because the firms testing has found it to be super potent based on an Out of Specification (OOS) result obtained at the 18-month stability timepoint.

Risk Statement: Use of the super potent product would result in a higher than intended lidocaine dose above that intended.  An increased lidocaine dose could lead to the development of local anesthetic systemic toxicity depending on the duration of the treatment and the specific patient.  Local anesthetic systemic toxicity can result in central nervous system reactions including excitation and/or depression and more serious signs of cardiovascular toxicity, such as bradycardia, hypotension, and even cardiovascular collapse can present very quickly.

If local anesthetic systemic toxicity is not recognized and treated quickly, severe morbidity and even death can result. Adults and the elderly who are more likely to use this product as well as children of lower body weight are more likely to experience local anesthetic systemic toxicity if a higher than intended lidocaine concentration is administered.

To date, Teligent Pharma, Inc. has not received any reports of adverse events related to this recall. The product is indicated for the production of topical anesthesia of accessible mucous membranes of the oral and nasal cavities and proximal portions of the digestive tract and is packaged in a 50ml glass bottle with a screw cap with the identification NDC# 52565-009-50.  The affected Lidocaine HCl Topical Solution 4% lot number and expiration date are:  Lot # 14218, Exp. 09/2022.  The product can be identified by the following labeling:  Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL).  

Product was distributed at the wholesale and retail distribution levels in the US and Canada. Teligent Pharma, Inc. is notifying its distributors via Fed-Ex and is arranging for return of all recalled products. Distributors, consumers, and patients that have Lidocaine HCl Topical Solution 4% which is being recalled should return product to their place of purchase.

Consumers with questions regarding this recall can contact Teligent Pharma, Inc. by phone at 1-856-697-1441 press * to reach the medical information call center Monday through Friday, 8am – 5pm. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Check the full recall details on fda.gov

Source: FDA
See Less

Company name: Pfizer
Brand name: CHANTIX
Product recalled: Varenicline tablets
Reason of the recall: N-nitroso-varenicline above acceptable daily intake level
FDA Recall date: September 16, 2021
Recall details: Pfizer is voluntarily recalling all lots of Chantix 0.5 mg and 1 mg Tablets to the patient (consumer/user) level... See More due to the presence of a nitrosamine, N-nitroso-varenicline, at or above the FDA interim acceptable intake limit. As alternative suppliers have been approved in the United States, Pfizer is undertaking this precautionary measure. Long-term ingestion of N-nitroso-varenicline may be associated with a theoretical potential increased cancer risk in humans, but there is no immediate risk to patients taking this medication. Check the link below for the full list of the recalled products.

The health benefits of stopping smoking outweigh the theoretical potential cancer risk from the nitrosamine impurity in varenicline. Nitrosamines are common in water and foods, including cured and grilled meats, dairy products and vegetables. Everyone is exposed to some level of nitrosamines. These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.

Chantix is a treatment to help patients quit smoking and is intended for short-term use. People who smoke cigarettes are 15 to 30 times more likely to get lung cancer than people who do not smoke.

Smoking is also associated with many other cancers, as well as with cardiovascular disease and lung disease. CHANTIX has a safety profile that has been established over 15 years of marketing authorization and through a robust clinical program. Pfizer believes the benefit/risk profile of CHANTIX remains positive. Patients currently taking Chantix should consult with their healthcare provider about alternative treatment options.

To date, Pfizer has not received reports of adverse events assessed to be related to this recall. The NDC, Lot Number, Expiration Date, and Configuration details for Chantix Tablets are indicated in Appendix A. Photos of the products can be found in Appendix B.

The products were distributed nationwide to Wholesalers and Distributors in the United States, US Virgin Islands, and Puerto Rico from May 2019 to September 2021. Pfizer places the utmost emphasis on patient safety and product quality at every step in the manufacturing and supply chain process. Pfizer has notified their direct consignees by letter to arrange for return of any recalled product.

Wholesalers and Distributors with an existing inventory of Chantix tablets, should stop use and distribution and quarantine the product immediately. If you have further distributed the recalled product, please notify any accounts or additional locations which may have received the recalled product from you. Please conduct a sub-recall to those accounts and communicate this recall information immediately.

If you received free product through the Pfizer Patient Assistance Program (PAP) or the Pfizer Institutional Patient Assistance Program (IPAP), please check your stock immediately. Additionally, if you are aware of any patients to whom you dispensed the products and who still may have the product in their possession, please ask them to return the product.

As communicated by FDA, there is no immediate risk to patients taking Chantix.iv Patients who are taking this product should consult with their health care provider to determine if alternative treatments are available.

Check the full recall details on fda.gov

Source: FDA
See Less

The FSAI announced the recall of unauthorized novel CBD food supplements due to the presence of unsafe levels of delta‐9‐tetrahydrocannabinol (THC) based on the European Food Safety Authority (EFSA) acute reference dose.

The recalled products are:
- Jacob Hooy, 2.75%CBD+, 10 ml, Batch number: 060977-0302, Best before... See More date: Feb-2022.
- Greenway, CBD Hemp Oil, 10 ml, Batch number: CB60001, Best before date: 10/12/2022.
- The Hemp Company, CBD Oil Original, 10 ml, Batch number: 10-10-139, Best before date: 04/2022.

FSAI requested to distributors withdraw the product from the market, and Retailers remove the products from sale. Consumers should not purchase or consume any of the implicated batches of the unauthorized novel CBD food supplements.

For more recall details check on FSAI website: fsai.ie

Source: FSAI
See Less

The FSAI announced the recall of Aptonia sports food products by Decathlon due to the presence of the unauthorized pesticide ethylene oxide. Ethylene oxide is a pesticide that is not permitted for use in foods sold in the EU but is approved for use by other countries... See More outside the EU.

The recalled products are:
- Aptonia Vitamins and Minerals 30 tablets Orange flavour
- Aptonia salts caps 100 capsules
- Aptonia Electrolytes tablets Ecosize lemon flavour 2x20 tablets
- Aptonia Electrolytes tablets rasperry flavour 2x20 tablets
- Aptonia Electrolytes tablets lemon flavour 2x20 tablets

Although the consumption of the contaminated product does not pose an acute risk to health, there is an increased risk if there is continued consumption of contaminated food over a long period of time. Therefore, exposure to this substance needs to be minimized.

In case you are experiencing food poisoning symptoms, it is important to report it. It can help to detect & resolve outbreaks early and prevent others from being harmed, and it enables better surveillance.

For more recall details check on FSAI website: fsai.ie

Source: FSAI
See Less

I was given the second dose of the vaccine and everything was very fast in the Benalcazar, there was practically no one and a side effect I only had a little pain in my arm for a day and a half | Symptoms: Soreness See Less

Some individuals are fearing maybe the vaccines contain virus

Some people are not willing to be vaccinated against the virus which sometimes may lead to the rapid spread of the virus See Less

I ordered a wood cutter, chain saw, rechargeable on 3/18/21.  The linked showed up on Facebook.  I did not receive my chain saw.  Apparently the company, Amphitrite Technology Limited has been scamming people all year.  It wasn’t until I found your website that I realized I had... See More been sent this weird chain, hand cutter.  There are many pictures posted on your site of the same product.  I had no idea why this thing came to me.  I did not think it was a “replacement” or substitute for the little chain saw that was rechargeable.   

I can see there are several posts about the same problem. What can be done? Why has PayPal continued to allow the seller to sell? What can you do? What can I do, to stop others from the company”s fraud?

I purchased through PayPal; directly after this purchase my bank notified me that someone tried to buy a cell phone. What happens next? With so many reports of fraud, why hasn’t the seller been reported to officials? What can you do? What can I do on my part? I contacted PayPal. The company should be blocked from selling
See Less